Superior Vena Cava Reconstruction in Patients on Hemodialysis

CompletedOBSERVATIONAL
Enrollment

45

Participants

Timeline

Start Date

September 13, 2014

Primary Completion Date

May 6, 2022

Study Completion Date

May 6, 2022

Conditions
Superior Vena Cava Syndrome
Interventions
PROCEDURE

Superior vena cava reconstruction

Endovascular therapy with percutaneous transluminal angioplasty (PTA) and, in recent years, with stenting of the SVC, has been performed with increasing frequency. An endovascular approach is the current standard of care to relieve SVC obstruction due to malignancy to obtain prompt relief of the rapidly emerging symptoms and improve quality of life,3 keeping in mind the short life expectancy of these patients. The role of endovascular therapy in SVC syndrome of nonmalignant etiology is undecided because long-term durability of this treatment method remains to be assessed.

Trial Locations (1)

75203

Methodist Dallas Medical Center, Dallas

All Listed Sponsors
lead

Methodist Health System

OTHER

NCT04637334 - Superior Vena Cava Reconstruction in Patients on Hemodialysis | Biotech Hunter | Biotech Hunter